PharVision Advisers’s Snowflake SNOW Stock Holding History

PharVision Advisers’s Portfolio SNOW Stock Details SNOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-940	Closed	-$212K	–	982
2025 Q3	$212K	Buy	+940	New	+$202K	0.12%	467

Other funds holding SNOW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

PharVision Advisers's SNOW Position: Q4 2025 in Review

PharVision Advisers sold out of Snowflake (SNOW) in Q4 2025, closing a stake of 940 shares — an estimated $212K sold.

PharVision Advisers first reported a position in SNOW in Q3 2025 and held it in 1 quarter. The position peaked at $212K in Q3 2025. 1,399 funds tracked by Wall St. Rank hold SNOW as of Q4 2025.

PharVision Advisers reported no remaining Snowflake position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 940 Snowflake shares in Q4 2025, an estimated $212K.
PharVision Advisers first reported a position in Snowflake in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Snowflake position peaked at $212K in Q3 2025.
1,399 funds tracked by Wall St. Rank held Snowflake as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.